Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Ameratunga

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|September 15, 2025
Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disordersRohan Ameratunga, Euphemia Yee Leung, Hilary J Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Pathology|December 23, 2009
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemiaWeldon Chiu, Humphrey Pullon, See-Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 12, 2018
Reply to Crépeaux et al and BlascoRohan Ameratunga, David Gillis, Michael Gold, et al.
Frontiers in Immunology|December 15, 2016
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for CureRohan Ameratunga, Adam Bartlett, John McCall, et al.
The New Zealand Medical Journal|May 9, 2006
Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?Penny Fitzharris, Marianne Empson, Rohan Ameratunga, et al.
Clinical Reviews in Allergy & Immunology|December 1, 2025
Common Variable Immunodeficiency Disorders: A perspective from New ZealandRohan Ameratunga, Hilary J Longhurst, Klaus Lehnert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2022
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 13, 2019
The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemiaRohan Ameratunga, Yeri Ahn, Dominic Tse, et al.
Journal of Clinical Pathology|October 10, 2022
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|September 15, 2025
Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disordersRohan Ameratunga, Euphemia Yee Leung, Hilary J Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Pathology|December 23, 2009
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemiaWeldon Chiu, Humphrey Pullon, See-Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 12, 2018
Reply to Crépeaux et al and BlascoRohan Ameratunga, David Gillis, Michael Gold, et al.
Frontiers in Immunology|December 15, 2016
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for CureRohan Ameratunga, Adam Bartlett, John McCall, et al.
The New Zealand Medical Journal|May 9, 2006
Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?Penny Fitzharris, Marianne Empson, Rohan Ameratunga, et al.
Clinical Reviews in Allergy & Immunology|December 1, 2025
Common Variable Immunodeficiency Disorders: A perspective from New ZealandRohan Ameratunga, Hilary J Longhurst, Klaus Lehnert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2022
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 13, 2019
The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemiaRohan Ameratunga, Yeri Ahn, Dominic Tse, et al.
Journal of Clinical Pathology|October 10, 2022
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 10